The Oncomine database showed that YTHDF1 mRNA levels were significantly higher in most human cancers, such as bladder, brain and CNS, breast, cervical, colorectal, esophageal, head and neck, kidney, liver, lung, ovarian, pancreatic, prostate cancer, leukemia, melanoma, sarcoma, and other cancer types compared to the corresponding normal tissues. The gene discussed is YTHDF1; the disease is prostate cancer.